StockData
CERo Therapeutics Holdings, Inc. logo

CERo Therapeutics Holdings, Inc. (CERO) stock

CEROOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CEROW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.01+0.00 (0.00%)

Close on Oct 19, 2026Market cap $253.05KP/E –Yield 172833.33%

CERo Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

No price to book ratio figures for CERo Therapeutics

CERo Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More CERo Therapeutics figures

See a number that looks wrong?